WAY-252623 =98% (HPLC)

WAY-252623 =98% (HPLC)

Biochem/physiol Actions

WAY-252623 (LXR623) is an orally available, potent and highly selective Liver X receptors (LXRs) agonist that significantly reduced total and LDL-cholesterol. WAY-252623 reduces lesion progression in the murine LDLR(-/-) atherosclerosis model.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

Other Notes

This compound was developed by Pfizer for Lipid Signaling research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3573656 WAY-252623 =98% (HPLC) white to beige 100 SIGMA-ALDRICH room temp DMSO: 20 mg/mL, clear powder ≥98% (HPLC)
£533.46 (exc VAT) per 25MG
-
+
3573657 WAY-252623 =98% (HPLC) white to beige 100 SIGMA-ALDRICH room temp DMSO: 20 mg/mL, clear powder ≥98% (HPLC)
£136.50 (exc VAT) per 5MG
-
+